tirzepatide b6 injection with B-6 Compounded Tirzepatide Weight Loss Program

The STEER study investigated the risk of major adverse cardiovascular events (MACE) with Wegovy (semaglutide 2.4 mg) compared with tirzepatide treatment in people with overweight or obesity and established CVD without diabetes

Addressing issues like cataracts, glaucoma, or dry eye before starting the medication leads to better outcomes overall

Cost should be discussed before treatment begins, not after the medication starts working

NexLife is a LegitScript-certified telehealth platform and works exclusively with compounding pharmacies that hold LegitScript certification, NABP accreditation, and NCPA membership

The list identifies these drugs for which the agency is working to reduce the impact of the shortage